Research Papers

25 of 400 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Comparison of in-house SARS-CoV-2 genome extraction procedures. A need for COVID-19 pandemic.
Martín G; Rojo-Alba S; Castelló-Abietar C; Abreu-Salinas F; Costales I; Boga JA; Melón S; Álvarez-Argüelles ME.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
A fast and cheap in-house magnetic bead RNA extraction method for COVID-19 diagnosis.
Possebon FS; Ullmann LS; Malossi CD; Miodutzki GT; da Silva EC; Machado EF; Braga IS; Pelaquim IF; Araujo JP.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection.
Pezzuto A; Tammaro A; Tonini G; Conforti G; Falangone F; Spuntarelli V; Teggi A; Pennica A.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Assessment of SARS-CoV-2 viral loads in combined nasal-and-throat swabs collected from COVID-19 individuals under the U…
Mak GCK; Ng AYY; Lam ETK; Chan RCW; Tsang DNC.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protei…
Gomes L; Jeewandara C; Jayadas TP; Dissanayake O; Harvie M; Guruge D; Withanage V; Mahesh PKB; Rajapakse W; Ramachandran R; Dharmarajan V; Pathiraja I; Sanjeewani A; Bandara P; Nanayakkara G; Francis VR; Kithsiri A; Edirisinghe DA; De Silva K; Wijayamuni R; Ogg GS; Waggoner J; Malavige GN.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
In vitro evaluation of the effect of mutations in primer binding sites on detection of SARS-CoV-2 by RT-qPCR.
Zimmermann F; Urban M; Krüger C; Walter M; Wölfel R; Zwirglmaier K.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Evaluation of sample pooling using the SAMBA II SARS-CoV-2 test.
Heaney K; Ritchie AV; Henry R; Harvey AJ; Curran MD; Allain JP; Lee HH.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic.
Burdino E; Cerutti F; Panero F; Allice T; Gregori G; Milia MG; Cavalot G; Altavilla A; Aprà F; Ghisetti V.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents.
Haile S; Nikiforuk AM; Pandoh PK; Twa DDW; Smailus DE; Nguyen J; Pleasance S; Wong A; Zhao Y; Eisler D; Moksa M; Cao Q; Wong M; Su E; Krzywinski M; Nelson J; Mungall AJ; Tsang F; Prentice LM; Jassem A; Manges AR; Jones SJM; Coope RJ; Prystajecky N; Marra MA; Krajden M; Hirst M.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-…
Schirtzinger EE; Kim Y; Davis AS.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients wi…
Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA…
Krüttgen A; Lauen M; Klingel H; Imöhl M; Kleines M.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Loop-Mediated Isothermal Amplification assays for on-site detection of the main sweetpotato infecting viruses.
Wanjala BW; Ateka EM; Miano DW; Fuentes S; Perez A; Low JW; Kreuze JF.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers.
Krüttgen A; Klingel H; Haase G; Haefner H; Imöhl M; Kleines M.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Development of real-time RT-qPCR assays for the typing of two novel bluetongue virus genotypes derived from sheeppox va…
King S; Flannery J; Batten C; Rajko-Nenow P.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Validation of the analytical performance of nine commercial RT-qPCR kits for SARS-CoV-2 detection using certified refer…
Wang D; Wang Z; Gao Y; Wu X; Dong L; Dai X; Gao Y.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2.
Di Carlo D; Mazzuti L; Sciandra I; Guerrizio G; Oliveto G; Riveros Cabral RJ; Zingaropoli MA; Turriziani O.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
A rapid and simple protocol for concentration of SARS-CoV-2 from sewage.
Wehrendt DP; Massó MG; Gonzales Machuca A; Vargas CV; Barrios ME; Campos J; Costamagna D; Bruzzone L; Cisterna DM; Iglesias NG; Mbayed VA; Baumeister E; Centrón D; Quiroga MP; Erijman L.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
SARS-CoV-2 saliva testing is a useful tool for Covid-19 diagnosis.
de Oliveira CM; Brochi L; Scarpelli LC; Lopes ACW; Levi JE.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Evaluation of spike protein antigens for SARS-CoV-2 serology.
Jagtap S; K R; Valloly P; Sharma R; Maurya S; Gaigore A; Ardhya C; Biligi DS; Desiraju BK; Natchu UCM; Saini DK; Roy R.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Clinical usefulness of extraction-free PCR assay to detect SARS-CoV-2.
Kim YK; Chang SH.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiatio…
Ulloa S; Bravo C; Ramirez E; Fasce R; Fernandez J.
J Virol Methods (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Evaluation of virucidal activity of fabrics using feline coronavirus.
Camero M; Lanave G; Catella C; Lucente MS; Decaro N; Martella V; Buonavoglia C.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Comparison of eleven in vitro diagnostic assays for the detection of SARS-CoV-2 RNA.
Dundon WG; Settypalli TBK; Spiegel K; Steinrigl A; Revilla-Fernández S; Schmoll F; Naletoski I; Lamien CE; Cattoli G.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Accessioning and automation compatible anterior nares swab design.
Pettit ME; Boswell SA; Qian J; Novak R; Springer M.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared